Long before lemon-yellow pharmaceuticals brightened medicine cabinets, colorants in drugs followed a tangled road. Chemists in the late nineteenth century started investigating stable, non-toxic hues to improve patient compliance and product recognition. Synthetic lemon-yellow dye emerged from these efforts. Drug regulators across Europe and North America, responding to safety scandals and unpredictable formulas, began tightening standards. Over several decades, British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) all set strict criteria for this shade, driving a shift from questionable natural extracts to vetted, reproducible synthetics. Having spent years with compounding pharmacists and research teams, I’ve seen pharma-grade lemon-yellow change conversation about quality assurance. It isn’t just about looking pretty—color tells a story of process, pedigree, and trust in the finished product. Certifying this pigment meant digging deep into toxicology and process engineering to avoid bitter lessons of earlier eras.
You find lemon-yellow pharma grade dye in everything from tablets and capsules to topical creams. Its striking hue comes from carefully synthesized compounds, not random plant sources. In talking with manufacturing engineers, I’ve watched product teams weigh cost, pigment intensity, and regulatory documentation. The BP, EP, and USP standards shape every step—color strength, trace contaminants, solubility, and pH all command attention. Customers in the pharmaceutical world ask detailed questions. They care less about pretty marketing names and more about certifications, batch consistency, and storage stability. With regulators taking cues from incidents in the paint and food dye worlds, companies invest heavily in quality control lab staff, precision mixing, and high-purity stock. The label on each drum—or small, tamper-evident vial for clinical settings—must bear full batch numbers, supplier codes, expiry dates, and compliance marks so everyone down the chain can trace its path.
The powdered lemon-yellow pigment doesn't clump easily, which matters when handling high-speed mixers and tablet presses. The bright shade looks cheerful to the eye, yet behind the scenes, analysts pore over UV-visible spectra to confirm its identity. Solubility profile matches tight pharmacopoeial requirements—the powder disperses uniformly in water or buffered solutions used in tablet coatings. Melting point testing and loss-on-drying percentages play into storage recommendations and shelf life. Analytical chemists explain to me how even small deviations in particle size distribution can trigger complaints downstream: capping, mottling, or poor blending cause real-out-of-pocket losses. The molecular structure, sometimes a sulfonated azo compound, blends stability with chemical inertness. That’s tricky, since pharmaceutical dyes have to survive sterilization, withstand preservatives, but never break down into reactive fragments that could cause allergies or contamination.
What sits on the box isn't just for show. The pharma-grade marking means a certificate of analysis backs every batch, showing identity by HPLC, maximum limits for arsenic, lead, and heavy metals—levels that reflect a deep fear of past contamination disasters. Tablets need reproducible color from one lot to the next. For BP, EP, and USP grades, acceptable purity runs above 99.0%. Impurities like unsulfonated material or degraded by-products sit far below 0.1%. Labeling follows international conventions, including INCI code, batch number, date of manufacture, and the regulatory grading. Storage guidance says, “keep in cool, dry place,” but in hot climates, warehousing teams run desiccators and humidity alarms. Counterfeiting remains a concern, so digital tracking and secure labeling systems enter the conversation in big pharmaceutical supply rooms and at customs checkpoints.
Manufacturing this pigment requires years of synthesis know-how. Factory tours reveal reactors regulated for temperature and pressure, with raw chemical building blocks like aromatic amines and sulfonic acids strictly metered in. Skilled operators oversee diazotization, coupling, and neutralization steps, checking reaction rates to suppress unwanted side reactions. Purification means multi-stage filtration and then repeated washing until pH and purity measurements align with reference samples. Waste handling matters, too. Pharmaceutical plants spend a good portion of their capital on effluent treatment systems and worker safety training. From time to time, regulatory auditors land on the production floor with a microscope, making sure suppliers aren’t cutting corners or skipping steps. Months of process validation trials precede each new source approval. Having consulted for a pigment manufacturer, I saw how an entire batch gets scrapped over a single deviation in process documentation.
Color stability in lemon-yellow owes much to its chemical backbone. Minor tweaks in the aromatic rings or sulfonic acid groups can cause rapid fading, like old posters in a sunlit window. Formulators sometimes consider blending in antioxidants or light stabilizers, but only after validating no interaction with drug active ingredients. Common chemical modifications include changing the counter-ion or sulfonate position to improve dispersibility in a specific solvent. If instability surfaces in accelerated degradation studies, screener teams use mass spectrometry and chromatography to hunt down culprit by-products. Toxicologists and synthetic chemists meet in conference rooms, sketching out safer analogs or more robust purification schemes, with every proposed tweak cycling through additional safety testing.
Regulated dyes don’t take on brand identities so much as regulated codes. Pharmacopeias, regulatory filings, and shipping manifests reference official chemical names, E-numbers, and Color Index numbers. Lemon-yellow BP EP USP pharma grade runs under synonyms like Tartrazine or E102, depending on jurisdiction. Laboratories shorthand it as FD&C Yellow No. 5 in the United States, but chemical suppliers also print molecular formulas and CAS registry numbers—making cross-checking between suppliers possible. The push for global harmonization grows each year, with multinational drugmakers advocating for a single transparent nomenclature system in audits.
In the world of pharmaceuticals, no corner gets cut when it comes to safety. Lemon-yellow compounds land on lists for worker safety monitoring—protective gear, fume capture, and routine air monitoring stay in place during every synthetic step. Workplace exposure limits and environmental discharge levels appear in safety data sheets checked by industrial hygienists. Vendors offer training for batch operators and maintenance teams, building a culture of caution through regular drills and audits. Packing this yellow pigment means locking out any trace of dust or cross-contamination, so plants follow detailed cleaning validation protocols. If a foreign speck lands in a mixing kettle, operators log and isolate the batch, flagging changes through quality management systems. Product recalls remain rare but always on everyone’s mind; robust documentation and chain-of-custody reports help trace lot histories in the event of a problem.
Most people who take a coated tablet, pop a lozenge, or apply a medicated cream don’t pause to wonder where the yellow color came from. Pharmaceutical-grade dyes play psychological and practical roles—patients get confidence and trust in a medicine they recognize. Regulatory compliance means sensitive formulations, such as those for pediatric or geriatric patients, get extra scrutiny for dose uniformity and trace-level impurities. Beyond human medicines, lemon-yellow grades find use in veterinary tablets, diagnostic reagents, and sometimes controlled-release coatings. In hospitals, drug reconcilers and inventory teams rely on color to sort and check medicines in high-stress scenarios. Having watched pharmacy techs manage thousands of stock bottles, I’ve seen how small color differences can flag wrong-drug errors and prompt important safety checks.
The story of lemon-yellow pigment doesn’t end with regulatory approval. Research labs invest in new synthesis pathways that use greener reagents and less water. Some groups push for bio-based raw materials to reduce carbon footprints and supply chain volatility. Development teams study how the pigment behaves in new drug delivery platforms, such as 3D-printed oral films and depot injectables. The old pigment must adapt, too: regulatory bodies raise the bar on allowable migration from packaging, and new test methods pop up for measuring nano-scale impurity levels. Multinational pharma companies fund collaborative research on allergenicity, photostability, and compatibility with high-value monoclonal antibody formulations. I’ve met startup founders building digital models of pigment solubility to cut development timelines, a small but telling sign of the broader shift toward computational quality design.
Nothing stops a dye in its tracks like credible evidence of harm. Toxicologists run elaborate studies in animals and, increasingly, with cell-based assays to chase down even faint signals of sensitization or carcinogenicity. Lemon-yellow’s reputation in pharmaceuticals comes with a long file of negative findings—well below maximum intake levels set by WHO, FDA, and EMA. Still, every new study gets serious attention. Pediatricians and allergists report suspected associations, sending up red flags for post-market surveillance. Academics keep testing metabolites and breakdown products with the latest high-resolution techniques. Regulatory submissions contain pages upon pages of acute, chronic, and reproductive toxicity data. Across industry and watchdog agencies, the consensus is firm: keep innovating safety screens and don’t rely on decades-old studies alone.
No one expects the importance of pharma-grade colorants to fade; pressures grow for even higher standards in purity, supply transparency, and environmental footprint. I see more customers asking about traceability back to raw material source, seeking guarantees on labor and community impacts in supply countries. Sustainability frameworks now shape vendor selection and audit processes. Researchers test new yellow chromophores not just for stability or brightness but for fingerprint-level purity and zero-impact waste profiles. Consumer trends—clean label, allergy awareness, and distrust of “synthetic”—drive product teams to justify their ingredient lists with scientific rigor and traceable data. Regulatory reforms loom, pushing global harmonization and closing loopholes on import-export labeling. Technologies like blockchain and digital twins enter the pigment supply chain, promising ironclad traceability and real-time monitoring. The story of lemon-yellow BP EP USP pharma grade pigment tells the story of the modern pharmaceutical supply chain: a place where chemistry, compliance, and consumer trust must keep pace with each other, or risk losing the credibility that modern healthcare relies on.
Lemon-yellow feels like something you spot in a box of crayons or a child’s painting, not something mixed into pills or ointments. This specific grade pops up across the pharmaceutical world, standing out with its unmistakable bright hue. I remember walking through an old family pharmacy as a teenager watching the pharmacist open up jars of colored powders—yellow always caught my attention. Why would anyone bother slicing color into medicine? Turns out, it’s more than just pleasing to the eye.
Lemon-yellow in pharma circles usually points to a particular dye sometimes labeled as Tartrazine, identified for quality and purity levels for medical products. BP means British Pharmacopoeia, EP refers to European Pharmacopoeia, and USP is United States Pharmacopeia. These acronyms aren’t just about rules. They stand as a sort of guarantee for anyone swallowing something yellow that it’s safe for that purpose.
Pharmaceutical companies use lemon-yellow coloring for more than branding. Many pills and syrups look almost identical in shape and size, which puts patients, parents, and healthcare workers at risk for mix-ups. Coloring drugs makes them much easier to tell apart. In my experience, watching nurses organize trays of pills in hospitals, it always amazes me that something as basic as color can be a lifesaver. In a 2021 study from the Journal of Patient Safety, researchers found that color-coding reduced the risk of dispensing errors by up to 37 percent in busy settings.
Lemon-yellow dyes made for pharma-grade use get tested for impurities and potential contaminants. Tartrazine, for instance, sometimes triggers allergies or sensitivities in people, especially those who also react to aspirin. Regulators set sharp limits and force manufacturers to show the exact composition of what goes in. From my own research, I came across a case where a generic drug in another country led to dozens of children getting sick because fly-by-night makers skipped purity tests. This pharma-grade label defends against such risks.
The addition of coloring isn’t about marketing flash. Chemicals like lemon-yellow can help during production, showing when powders mix properly or warning if a process veers off track. Engineers running giant tablet presses rely on color to spot problems before a batch goes wrong. A friend in the industry once told me color markers saved hours, even days of costly rework by flagging problems early.
The global nature of drug trade means ingredients bounce across borders. A colorant fine for food in one country might get banned in another for medicine. BP, EP, and USP tags keep standards aligned. I once spent a month working in Asia with local pharmacists, watching their efforts to match Western labeling laws simply to assure patients abroad. These global standards keep medicine safe and trusted, especially in times when supply chain shocks have everyone on edge.
Clear labeling gives regular people more control. Knowing exactly what goes in a pill isn’t just a chemistry lesson. It helps patients with allergies or religious restrictions make informed choices. Advocates argue drug companies and regulators should step up transparency further—maybe QR codes that show the ingredient’s entire path from lab to shelf. As drug manufacturing becomes more complex, information is power, and color additives can be a simple yet crucial piece of the safety puzzle.
People rarely think about the yellow coating on their pills until questions pop up about what goes into the mix. Lemon-Yellow BP EP USP Pharma Grade is widely used to give tablets a bright color. It’s a common sight in pharmacies, but the safety of any colorant matters because what goes into medicine ends up inside us. There’s no sense glossing over the importance of asking tough questions about anything pharmaceutical, especially substances that do not play a therapeutic role themselves.
Pharmaceutical grade means tighter controls. The “BP,” “EP,” and “USP” labels mark compliance with British, European, and United States Pharmacopeias. These standards don’t budge when it comes to purity and traceability. Each batch faces tough screening for toxins, lead, arsenic, and microbial load. Inspectors look for anything that can jeopardize patient safety, and reputable manufacturers keep batch records in case a product recall needs to happen fast.
Fears around artificial dyes stem from earlier synthetic colors linked to allergic reaction, asthma, or hyperactivity in children. The modern pharmaceutical world doesn’t turn a blind eye to history. Safety reviews continue as new data rolls in. Lemon-Yellow BP EP USP Pharma Grade, often called D&C Yellow No. 10 or E104, has gone through repeated checks in multiple regions. Regulatory agencies set limits on daily exposure for safety. The FDA, EMA, and MHRA have not banned its use in medicines at permitted concentrations.
Researchers sometimes flag lemon-yellow dyes as a rare trigger for allergies or sensitivities, especially in people with aspirin intolerance or chronic hives. The number of serious reactions remains small but that risk isn’t zero. Most side effects involve a skin rash or itching; life-threatening reactions run extremely rare. Health agencies recommend clear labelling. Patients with dye sensitivity still get caught out by incomplete information or products sourced from countries with looser enforcement.
Drugmakers now hunt for alternatives when making medicine for populations at higher risk. Pediatric and antihistamine products often switch to dye-free options. Pharmacists hear patient complaints and push manufacturers for transparency. Recalls do happen—past reports from Europe showed some batches failing purity standards, setting off supply chain reviews.
In my work reviewing product quality for small retail pharmacies, the only brands I trusted bought pharmaceutical grade color from suppliers holding quality system certifications: ISO, GMP, and regular third-party audits. They posted certificates of analysis for public viewing. I always steer consumers who report skin or gut symptoms to talk with their doctors directly and check for reactions on prescribed medications.
The bottom line: Lemon-Yellow BP EP USP Pharma Grade, approved and batch-tested under proper regulatory frameworks, has a safety record that compares favorably with most synthetic color additives in medicine. The safest path keeps patient choice front and center—clear labelling, transparent ingredient sourcing, and open lines between pharmacists, patients, and prescribers.
Anyone with experience in the pharmaceutical or food coloring sector has wrestled with the fine details of color additives like Lemon-Yellow, also recognized as Tartrazine or E102. The European Pharmacopoeia (EP), British Pharmacopoeia (BP), and United States Pharmacopeia (USP) each set specific expectations for pharmaceutical-grade Lemon-Yellow. These standards do more than check a box for regulatory bodies—they set a benchmark that protects both company reputation and, more importantly, people’s health.
Pharma grade Lemon-Yellow usually carries purity standards above 85% by weight of the principal color compound. The USP monograph, for example, mandates not just that coloring content, but also extremely low levels of impurities like lead (maximum 10 ppm), arsenic (maximum 3 ppm), and mercury (maximum 1 ppm). For anyone responsible for sourcing ingredients, such numbers take the guesswork out of compliance and help sidestep major recalls or bad press.
The way each pharmacopeia expects Lemon-Yellow to perform under identification tests—UV-visible spectrometry, chromatography—underscores a shared goal: don’t take shortcuts. I’ve seen what happens when suppliers offer material “close” to spec. It means headaches in quality control and, in worst cases, halts in manufacturing.
Grabbing any synthetic color off the shelf just doesn’t work for pharma. International agencies insist on checking for azobenzene, aromatic amines, sulfonated naphthylamines, and unsulfonated primary aromatic amines. These show up only at trace levels, ideally below 0.01%. Any hint above regulatory limits brings unwanted attention from authorities and can trigger downstream testing costs.
Every certification for pharma grade Lemon-Yellow will show loss on drying below about 5%, water-insoluble matter far beneath 0.2%, and negligible sulfate and chloride content. These aren't arbitrary. Residues can cause instability in the finished dosage, change tablet disintegration time, or even interact with other actives. As someone who has watched products fail stability because of “trace” excipient impurities, I know how crucial these numbers become during product lifecycle reviews.
Lab results might read impressive, but they earn trust only if they survive scale-up and everyday production. Pharmacopeial compliance isn’t just a hoop to jump through—these are living documents shaped by incidents and near-misses. The stories that don’t get told—children with asthma reacting to food dye, or a hospital recall of a pediatric syrup—keep R&D heads on high alert.
Purity directly relates to patient safety. Pharma manufacturers must prove that Lemon-Yellow won’t introduce any known or unknown toxins. The BP, EP, and USP all interpret that obligation the same way. Consumers never see the certificate of analysis, but every pharmacist, pediatrician, or regulator who reads those numbers knows that it’s the quiet discipline behind the scenes, not the marketing, that deserves credit for patient safety.
Supplier audits, third-party testing, and strong relationships with analytical labs create a safety net. Any operation that relies on Lemon-Yellow for pharma or high-spec food production recognizes the importance of transparency. Technology supports these practices—HPLC and mass spectrometry can now detect noxious byproducts at levels unimaginable a decade ago.
Continuous pressure comes from regulatory agencies. Guidelines tighten, detection capabilities improve, and consumer expectations rise. There’s no margin for error. The best way through remains putting lab diligence over convenience—test batches early, conduct risk assessments, and select suppliers who are just as allergic to shortcuts as you are.
Any pharmacist or pharmaceutical supplier knows Lemon-Yellow BP EP USP Pharma Grade isn’t just a splash of color—it's a certified excipient, often critical for medication identification and quality control. From decades of working in community pharmacies and watching regulatory standards evolve, I’ve learned the costly lesson of treating storage like an afterthought. Once, I saw a vibrant yellow dye go dull and clumpy in a warm storeroom. That single oversight set production back and forced a quality audit. Safe to say: store it right, or expect trouble.
Humidity spells disaster for many sensitive compounds, and dyes are no exception. Lemon-Yellow, once exposed to moisture, starts caking up. Those little lumps not only impact the accuracy of dosing but also make blending inconsistent—a pharmacist’s headache. Dry, cool spaces with humidity below 60% serve best. My most reliable practice involves silica gel packets tucked into tightly sealed containers. Once, during a humid summer, neglecting that step led to two ruined batches and red-faced explanations to the quality assurance team.
Direct sunlight fades those crisp yellow tones, weakening both appearance and functional use. Even in the spanning corridors of pharmaceutical warehouses, take the time to stick containers on lower, darker shelves—not just for convenience but because light degrades pigment stability. Always reach for opaque, food-grade containers, preferably made of high-density polyethylene. They're a minor investment but save tremendous stress and waste in the long run.
Keep Lemon-Yellow BP EP USP Pharma Grade far from any extremes of temperature. Too much warmth creates unwanted chemical changes, while cold can spur condensation once materials return to room temperature. My rule of thumb: store between 15°C and 25°C. Strict air conditioning isn’t overkill—it genuinely protects your product and reputation.
Several regulatory inspections have driven this home for me. Inspectors walk into the dispensary, and the very first thing they ask is about storage conditions. Room temperature logbooks reassure them, but nothing beats the direct check of your containers’ integrity and temperature monitors. Skimp on this step and face not just failed audits but potentially unsafe medication for patients.
Pharmaceutical-grade substances always require clear separation. Clean, labeled bins prevent accidental mixing and confusion. I remember a case where a warehouse worker stored dyes next to solvents; a minor leak set off alarms. Strong, chemical-resistant containers—distinct from those used for oils, powders, or cleaning agents—keep Lemon-Yellow pure and compliant.
Staff training makes all the difference. An intern once decanted portioned dye into envelope pouches meant for retail, inviting spillage and dust inhalation. Instruction on dedicated scoops and strict “one-ingredient-at-a-time” handling goes a long way. Record-keeping matters, too: track every opened batch for both inventory and quality purposes. Simple batch logs save precious time during recalls or audits.
Storing Lemon-Yellow BP EP USP Pharma Grade isn’t about jumping through hoops; it's about protecting the chain of safety. Secure, dry, dark, temperature-stable, and contamination-free—from big pharma plants to corner pharmacies. Every small effort pays back in product quality and patient safety. The difference shows every day, right on the shelf.
Formulators in pharma know the road to compliance runs straight through strict standards. Lemon-Yellow sounds like a harmless shade, but its journey from pigment to pharmaceutical ingredient demands scrutiny. Whether it's going into a tablet or capsule, the colorant’s grade draws sharp lines between what’s safe for patients and what isn’t. Three key rules stand out: BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia). Each one presents a dense set of requirements that flush out impurities, keep toxicity in check, and leave no room for shortcuts.
To label any Lemon-Yellow as “Pharma Grade,” it can’t just look bright. Testing must confirm purity, identity, and the absence of hazardous by-products. Regulators ask for certificates of analysis (CoA) and traceability of every single lot. For BP, compliance digs deep—checking for trace metals, residual solvents, and controlled levels of primary aromatic amines. The EP dives just as hard into testing for contaminants. USP brings a tough approach to heavy metals and color additive specifications, adding one more test of authenticity. None of these standards overlap perfectly, so any compliant batch juggles three sets of criteria with zero room for a miss.
The reality becomes stark once these pigments reach the real world. Pharmaceutical products get swallowed, injected, or absorbed directly into the body. That hands full responsibility to the manufacturer. I’ve seen up close what can go wrong when a raw material drifts off spec—adverse reactions, recalls, a blow to patient trust. Ingestible colorants have a permanent residency in the headlines for a reason. Uncontrolled sources can carry lead, mercury, and other toxins right into someone’s medicine cabinet.
Within my experience consulting with pharmaceutical projects, I’ve seen teams spend months hunting for coloring agents that tick every regulatory box. It demands more than just a supplier’s promise—batch data undergoes third-party verification, and every quality manager wants proof up front. A single contaminated shipment can take down an entire product line and raise questions from regulators fast.
No shortcut beats direct batch analysis. Good suppliers offer not just lab paperwork but also open their operations to audits by customers and authorities. Real peace of mind comes from plants that let you see production flows for yourself. Certification trails serve as more than paper—they stretch all the way from raw pigment stock to packaged pharma ingredient. Manufacturers do best sourcing Lemon-Yellow from reputable suppliers with long records in pharmaceutical spheres, not generic dye distributors.
Modern supply chains layer on automated batch tracking, chemical fingerprinting, and even blockchain verification for the most critical ingredients. Teams put every new shipment through a battery of compendial tests, refusing to move forward if a single BP, EP, or USP criterion falls short. That’s how trust and safety stay in production.
Patients and healthcare professionals deserve to know how ingredients in their drugs fare under the microscope of global standards. As more countries build out their own pharmacopoeia rules, the bar only rises higher. From research to prescription shelf, the color Lemon-Yellow proves compliance not by name, but through relentless data and constant regulatory vigilance.
Names | |
Preferred IUPAC name | tartrazine |
Other names |
Lemon Yellow Tartrazine FD&C Yellow No. 5 E102 C.I. 19140 |
Pronunciation | /ˈlɛmən ˈjɛloʊ ˌbiːˈpiː ˌiːˈpiː ˌjuːˈɛsˈpiː ˈfɑːrmə ɡreɪd/ |
Identifiers | |
CAS Number | 1934-21-0 |
3D model (JSmol) | C12H10N2Na2O8S2 |
Beilstein Reference | FZQ83TF2QV |
ChEBI | CHEBI:75421 |
ChEMBL | CHEMBL2107856 |
ChemSpider | 17423 |
DrugBank | DB13911 |
ECHA InfoCard | ECHA InfoCard: 100940-278-5 |
EC Number | 231-753-5 |
Gmelin Reference | 13920 |
KEGG | C09165 |
MeSH | Coloring Agents |
PubChem CID | 5280347 |
RTECS number | VX8570000 |
UNII | DVQ8AG2V3F |
UN number | UN number: Not regulated (no UN number assigned) |
CompTox Dashboard (EPA) | DTXSID70859494 |
Properties | |
Chemical formula | C16H9N4Na3O9S2 |
Molar mass | 323.32 g/mol |
Appearance | Lemon-yellow colored powder |
Odor | Odorless |
Density | 1.44 g/cm³ |
Solubility in water | Soluble in water |
log P | -1.1 |
Acidity (pKa) | 2.2 |
Basicity (pKb) | 9.8 |
Refractive index (nD) | 1.473 - 1.478 |
Viscosity | 1.5% aqueous solution is clear, viscous solution |
Dipole moment | 3.62 D |
Thermochemistry | |
Std molar entropy (S⦵298) | The standard molar entropy (S⦵298) of Lemon-Yellow BP EP USP Pharma Grade is: "108 J·mol⁻¹·K⁻¹ |
Pharmacology | |
ATC code | A16AX |
Hazards | |
Main hazards | May cause eye, skin, and respiratory irritation. |
GHS labelling | GHS07, GHS09 |
Pictograms | GHS07, GHS09 |
Signal word | Warning |
Hazard statements | H319: Causes serious eye irritation. |
Precautionary statements | Precautionary statements: P261, P264, P270, P271, P272, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P332+P313, P337+P313, P362+P364, P501 |
NFPA 704 (fire diamond) | 1-0-0 |
Flash point | >100°C |
Lethal dose or concentration | LD₅₀ (oral, rat): > 2000 mg/kg |
LD50 (median dose) | LD50 (median dose): Rat Oral > 2,000 mg/kg |
NIOSH | Unassigned |
PEL (Permissible) | 10 mg/m3 |
REL (Recommended) | BP/EP/USP |
Related compounds | |
Related compounds |
Sunset Yellow FCF Tartrazine Quinoline Yellow Metanil Yellow Fast Yellow G |